Date published: 2026-5-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRIP15 Activators

TRIP15 Activators encompass a range of chemical compounds that indirectly augment the functional activity of TRIP15, primarily through modulation of various signaling pathways and cellular processes. Forskolin, by increasing cAMP levels and activating PKA, indirectly influences ubiquitination processes where TRIP15 is involved, enhancing its functional activity in protein regulation. Rapamycin, as an mTOR inhibitor, and LY294002, a PI3K inhibitor, both alter cellular metabolic responses and AKT signaling, respectively. These alterations can indirectly enhance TRIP15's role in protein ubiquitination and degradation. Similarly, U0126 and SB203580, inhibitors of MEK1/2 and p38 MAPK, respectively, shift cellular signaling in a way that could enhance TRIP15's activity in ubiquitin-mediated processes. Wortmannin, another PI3K inhibitor, and Thapsigargin, which elevates intracellular calcium levels, both have potential to augment TRIP15's function by affecting interconnected signaling pathways related to protein stability and degradation.

Staurosporine, a broad-spectrum kinase inhibitor, and Epigallocatechin gallate, also a kinase inhibitor, influence various cellular signaling pathways, potentially enhancing TRIP15's role in ubiquitination processes. Sphingosine-1-phosphate, involved in lipid signaling, can indirectly affect TRIP15's functional activity by altering protein regulation mechanisms. A23187, by increasing calcium levels, activates calcium-dependent pathways that intersect with ubiquitin-proteasome systems, potentially enhancing TRIP15's involvement in these processes. Bortezomib, a proteasome inhibitor, can indirectly enhance TRIP15's activity within the ubiquitin ligase complex by altering protein turnover dynamics. Collectively, these TRIP15 Activators, through their targeted effects on cellular signaling and protein regulation pathways, facilitate the enhancement of TRIP15-mediated functions, particularly in ubiquitin-mediated protein regulation, without the need for upregulating its expression or direct activation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels and activating PKA. This can indirectly enhance TRIP15's activity in the ubiquitin ligase complex.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that shifts cellular metabolic and growth responses, potentially enhancing TRIP15's role in protein regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor disrupting AKT signaling, potentially enhancing TRIP15's role in ubiquitin-mediated regulation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that can influence stress responses and protein stability, potentially affecting TRIP15's activity in the ubiquitination pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A potent PI3K inhibitor, altering AKT pathway signaling and potentially enhancing TRIP15's functional role in ubiquitin-mediated protein regulation.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Raises intracellular calcium levels, potentially activating pathways that enhance TRIP15's activity in ubiquitin ligase complexes.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A broad-spectrum protein kinase inhibitor that can indirectly affect ubiquitination processes involving TRIP15.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Involved in lipid signaling and can affect cellular processes related to protein stability and degradation, potentially enhancing TRIP15's functional activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

A kinase inhibitor that might indirectly affect the ubiquitin-mediated processes where TRIP15 is involved, enhancing its functional activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

An ionophore increasing intracellular calcium levels, activating pathways that intersect with the ubiquitin-proteasome system, potentially enhancing TRIP15's role.